Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NeoStem has signed a stem cell collection center agreement with the University of Louisville Hospital/James Graham Brown Cancer Center.
Subscribe to our email newsletter
NeoStem acquired the exclusive worldwide rights to very small embryonic-like (VSEL) stem cell technology developed by researchers at the University of Louisville in November 2007. NeoStem’s VSELs have been identified in adult bone marrow and resemble embryonic stem cells both morphologically and transcriptionally. The company expects VSELS to serve as the basis for its entry into the therapeutic market place.
Robin Smith, chairman and CEO of NeoStem, said: “This is an extraordinary agreement for NeoStem and University of Louisville that will allow us to move adult stem cell therapies forward, both at the basic science and translational level.”